Skip to main content
Log in

Predictive value of fibrin monomers in postoperative deep vein thrombosis

  • Originals
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Intravascular activation of the coagulation system produces disseminated intravascular coagulation or deep vein thrombosis and is characterized by the occurrence of circulating soluble fibrin monomer complexes (FM) in plasma. In order to evaluate the prognostic and diagnostic value of this parameter in 156 patients with fractures of the femur, neck of the femur, tibia, and fibula, and with knee-joint or elective hip surgery, soluble fibrin monomer complexes (FM) were determined using the FM Test from Boehringer Mannheim/Diagnostica STAGO (erythrocyte agglutination test according to Largo). Plasma samples were taken prior to and on the 1st, 2nd, 3rd, 5th, 7th, and 9th postoperative day. Diagnosis of DVT was carried out by 125-I-labelled fibrinogen test in parallel. Positive results were checked by phlebography on the 7th or 9th postoperative day. Positive FM results were obtained in only 26% of patients without DVT. In 34 of 36 patients (94%) with postoperative DVT confirmed by phlebography, on the other hand, elevated FM levels were detected 2–4 days before the 125-I-labelled fibrinogen test gave positive results. The predictive value calculated on the basis of elevated FM levels is 63–73%. These results show that the FM Test allows early detection of a prethrombotic state in the development of postoperative DVT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

FM:

fibrinmonomer

s.c.:

subcutaneous

aPTT:

activated partial thromboplastin time

TT:

thrombin time

% RTA:

residual thrombin activity

SFMC:

soluble fibrin monomer complexes

DVT:

deep vein thrombosis

AT III:

antithrombin III

References

  1. Brockhaus W, Bruhn HD, Schlebusch H, Schöndorf TH, Tilsner V (1982) Erprobung einer chromogenen Bestimmungsmethode für low-dose-Heparin. Unveröffentlichte Ergebnisse

  2. Contant G, Gouault-Heilmann M, Martinoli JL (1983) Heparin inactivation during blood storage: its prevention by blood collection in citric acid, theophylline, adenosine, dipyramidole-CTAD-mixture. Thromb Res 31:365–374

    Google Scholar 

  3. Kakkar VV (1989) Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis. Am JSurg 157:413–418

    Google Scholar 

  4. Ku\mann J (1986) Probleme der Thromboembolieprophylaxe mit niedrig dosierten Heparin. Langenbecks Arch Chir 369:473–478 (Kongre\-bericht 1986)

    Google Scholar 

  5. Ku\mann J, Boehnke J, Kückelhaus HG, Herbold U (1988) Erfahrungen mit der Thromboseprophylaxe unter Verwendung von nicht fraktioniertem Heparin bei Patienten mit Frakturen des koxalen Femurendes. In: Weber U, Schöndorf TH (Hrsg) Thrombose und Embolie. Thieme, Stuttgart New York

    Google Scholar 

  6. Ku\mann J (1988) Probenaufbereitung zur Heparinbestimmung mit einem thrombocytenprotektiven Cocktail. Lab Med 12:244–245

    Google Scholar 

  7. Largo R, Heller V, Straub P (1976) Detection of soluble intermediates of the fibrinogen-fibrin-conversion using erythrocytes coated with fibrin monomers. Blood 47:991–1002

    Google Scholar 

  8. Leyvraz P (1983) Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep vein thrombosis after total hip replacement. N Engl J Med 309:954–958

    Google Scholar 

  9. Lill H, Röschlau P, Witt I (1983) Photometrischer Kontroll-test für die Low Dose-Heparintherapie. In: van de Loo J, Asbeck F (Hrsg) HÄmostase, Thrombophilie und Arteriosklerose, Berichtsband 2. Kongre\ für Thrombose und HÄmostase Münster 1982, Schattauer, Stuttgart, S 238

    Google Scholar 

  10. Oehler G, Klaus H, Stötzer KE, Spanuth E (1987) Der Nachweis von löslichen Fibrinmonomer-Komplexen. Methodenvergleich eines Erythrozyten-Agglutinationstests nach Largo (FM-Test) mit dem Ethanol-Gelierungs-Test. Lab Med 11:25–30

    Google Scholar 

  11. Planes A (1988) Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular heparin in patients undergoing total hip replacement. Thromb Haemost 60:407–410

    Google Scholar 

  12. Schöndorf TH (1981) Wertigkeit und Grenzen der Low-dose-Heparin-Prophylaxe zur Verhütung postoperativer thromboembolischer Komplikationen. Haemostaseologie 1:143–150

    Google Scholar 

  13. Schöndorf T, Paplham H, Franz K (1983) Determination of heparin partial thromboplastin time and antithrombin III after subcutaneous heparin administration. In: Witt I (ed) Heparin. New biochemical and medical aspects. deGruyter, Berlin New York, pp 315–327

    Google Scholar 

  14. The European Fraxiparin Study (EFS) Group (1988) Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. Br J Surg 75:1058–1063

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vogel, G., Spanuth, E. Predictive value of fibrin monomers in postoperative deep vein thrombosis. Klin Wochenschr 68, 1020–1026 (1990). https://doi.org/10.1007/BF01646548

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01646548

Key words

Navigation